Farther Finance Advisors’s Regencell Bioscience RGC Stock Holding History

Farther Finance Advisors’s Portfolio RGC Stock Details RGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-201	Closed	-$6.78K	–	6088
2026 Q1	$6.78K	Sell	201 -247	-55%	-$6.99K	﹤0.01%	4336
2025 Q4	$9.41K	Buy	448 +126	+39%	+$2.05K	﹤0.01%	3965
2025 Q3	$4.97K	Buy	322 +272	+544%	+$3.9K	﹤0.01%	3770
2025 Q2	$852	Buy	+50	New	+$610	﹤0.01%	3936

Other funds holding RGC

FRM

Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return

CIBC Asset Management Toronto, Ontario, Canada $45.6B AUM 44.74% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

BFS

Bare Financial Services Gap, Pennsylvania $436M AUM 20.22% 1-Year Est. Return

Farther Finance Advisors's RGC Position: Q2 2026 in Review

Farther Finance Advisors sold out of Regencell Bioscience (RGC) in Q2 2026, closing a stake of 201 shares — an estimated $6.78K sold.

Farther Finance Advisors first reported a position in RGC in Q2 2025 and held it in 4 quarters. The position peaked at $9.41K in Q4 2025. 8 funds tracked by Wall St. Rank hold RGC as of Q2 2026.

Farther Finance Advisors reported no remaining Regencell Bioscience position as of Q2 2026 after selling out during the quarter.
Farther Finance Advisors sold 201 Regencell Bioscience shares in Q2 2026, an estimated $6.78K.
Farther Finance Advisors first reported a position in Regencell Bioscience in Q2 2025 and held it in 4 quarters.
Farther Finance Advisors's Regencell Bioscience position peaked at $9.41K in Q4 2025.
8 funds tracked by Wall St. Rank held Regencell Bioscience as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.